AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 27- Open
- $0.15
- 52-wk high
- $3.14
- High
- $0.16
- 52-wk low
- $0.14
- Low
- $0.15
- Prev close
- $0.15
- Mkt cap
- $7.7M
- Volume
- 6.15M
- Fwd P/E
- 15.2x
- Beta
- 0.28
- P/S
- 0.1x
- P/B
- 445.3x
- Profit margin
- -47.9%
- Op margin
- +21.3%
- ROE
- -314.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about SURG filings
Are insiders buying or selling Surgepays Inc (SURG) stock?
Neither. Surgepays Inc (SURG) insiders filed no open-market purchases or sales in the 90 days to Sep 27, 2026, according to SEC Form 4 filings.
Which members of Congress have traded SURG recently?
None. No member of Congress disclosed a SURG trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this SURG smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
6 funds hold a position and insiders have been net buying.
What insiders are doing
Buys (1)
- MD
May David Allen
$21K
bought
How top traders are positioned
No tracked top-trader positions in SURG right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 145.5% above what analysts expected.
Earnings per share
-$0.11 expected
Reports Nov 11, 2026, in 45 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -47.9%
- Forward P/E
- 15.15
- Market cap
- $8M
Valuation
- P/S0.12
- P/B445.31
Quality
- Operating margin21.3%
- ROE-314.3%
- ROA-122.8%
Growth
- Beta0.28
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace